[pTyr5] EGFR (988-993) (TFA) Catalog No.:M15036-2 making hFAS an attractive metabolic

making hFAS an attractive metabolic target for the treatment of cancer

The IC50 for suppression of the HIV-2 strains ROD and EHO is 12

Long-term selection for Lenalidomide resistance in H929 myeloma cell lines is accompanied by a reduction in CRBN

is potentially for the treatment of malaria

Smiles: CC(C)C[C@H](NC(=O)C1=CC2C(=CC=CC=2OC)N1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO

[pTyr5] EGFR (988-993) (TFA) Catalog No.:M15036-2 making hFAS an attractive metabolic[pTyr5] EGFR (988 993) TFA is derived from the autophosphorylation site (Tyr992) of epidermal growth factor receptor (EGFR 988 993). [pTyr5] EGFR (988 993) TFA is often complexed with the catalytically inactive protein tyrosine phosphate 1B (PTP1B). Product information Molecular Weight: 918. 72 Formula: C33H46F3N6O19P Chemical Name: (2S, 5S, 8S, 11S, 14S, 17S) 17 amino 8 (2 carboxyethyl) 11 (carboxymethyl) 2 isobutyl 14 methyl 4, 7, 10, 13, 16